title: A1166C polymorphism of the angiotensin II type 1 receptor gene and risk of adverse events after coronary catheter interventions.
abstract: BACKGROUND
  Contradictory reports exist concerning the role of the angiotensin II type 1 receptor A1166C polymorphism as a coronary risk factor. Moreover, it is unknown whether the A1166C polymorphism is associated with thrombotic complications after coronary catheter interventions.
  
  
  METHODS
  We investigated the role of the A1166C polymorphism as a risk factor in 1000 patients with coronary artery disease (CAD) and in 1000 age- and sex-matched controls. A total of 649 patients receiving interventions (270 coronary angioplasty, 102 atherectomy, and 277 stenting) were investigated for a 30-day composite end point including target vessel revascularization, myocardial infarction, or death.
  
  
  RESULTS
  The composite end point was reached by 42 patients (6.5%) without evidence that the C allele was associated with excess procedural risk (odds ratio 0.93; 95% confidence interval 0.79-1.75; P =.82). Further analyses by device failed to show linkage with adverse events complicating coronary angioplasty, atherectomy, and stenting. Moreover, in the entire CAD group (n = 1000), the polymorphism even showed a trend to underrepresentation (odds ratio 0.83; 95% confidence interval 0.69-1. 004, P =.054).
  
  
  CONCLUSIONS
  These results indicate that the A1166C polymorphism neither represents a risk factor for adverse events complicating coronary interventions nor seems to have significant impact on further long-term processes such as development and severity of CAD.
authors.affiliation: Medizinische Klinik und Poliklinik, Campus Mitte, Berlin, Germany. karl.stangl@charite.de
authors.forename: K
authors.initials: K
authors.lastname: Stangl
authors.forename: I
authors.initials: I
authors.lastname: Cascorbi
authors.forename: V
authors.initials: V
authors.lastname: Stangl
authors.forename: M
authors.initials: M
authors.lastname: Laule
authors.forename: P M
authors.initials: PM
authors.lastname: Mrozikiewicz
authors.forename: M
authors.initials: M
authors.lastname: Schwarz
authors.forename: S B
authors.initials: SB
authors.lastname: Felix
authors.forename: H
authors.initials: H
authors.lastname: Theres
authors.forename: G
authors.initials: G
authors.lastname: Baumann
authors.forename: I
authors.initials: I
authors.lastname: Roots
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000379:methods; D016022:Case-Control Studies; D016001:Confidence Intervals; D003327:Coronary Disease / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D003328:Coronary Thrombosis / Q000453:epidemiology / Q000209:etiology / Q000235:genetics* / Q000628:therapy; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D011336:Probability; D011379:Prognosis; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin / Q000235:genetics*; D012016:Reference Values; D012307:Risk Factors
chemical_list: D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin